How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Non-surgical Cellulite Reduction Treatment Market
- By Treatment Technology: Radiofrequency (RF) Therapy, Laser Therapy, Acoustic Wave Therapy, Cryolipolysis, Ultrasound Therapy
- By End-User: Dermatology Clinics, Medical Spas, Plastic Surgery Clinics, Beauty Salons, Home Use Devices
- By Application Area: Thighs, Buttocks, Abdomen, Arms, Hips
- By Treatment Modality: Monopolar RF, Bipolar RF, Multipolar RF, Fractional Laser, Non-fractional Laser
- By Patient Demographics: Female Patients, Male Patients, Postpartum Women, Middle-aged Adults, Young Adults
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Radiofrequency (RF) Therapy leads By Treatment Technology at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 17 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 310 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.186 →
- 12 Company Profiles 17 players: SWOT & benchmarking p.194 →
Full report · locked preview
Everything inside the Non-surgical Cellulite Reduction Treatment Market report
A complete, evidence-based study - 12 chapters and 130 sections covering market size, segmentation across 5 axes, regional analysis and 17 company profiles, forecast to 2033.
Segmentation covered
Treatment Technology 5
End-User 5
Application Area 5
Treatment Modality 5
Patient Demographics 5
Companies profiled
Cynosure Inc.
Cutera Inc.
Syneron Medical Ltd.
BTL Industries Inc.
Venus Concept Inc.
Alma Lasers Ltd.
Lumenis Ltd.
Solta Medical
Inc. (a division of Bausch Health Companies)
Sciton Inc.
InMode Ltd.
Hologic
+5 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
17 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Cynosure Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Cutera Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Syneron Medical Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →BTL Industries Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Venus Concept Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Alma Lasers Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Lumenis Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Solta Medical
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Inc. (a division of Bausch Health Companies)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Sciton Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →InMode Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Hologic
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Inc. (including the Cynosure brand)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.227 →Zimmer MedizinSysteme GmbH
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →EndyMed Medical Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Fotona d.o.o.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →BTL Aesthetics
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.250 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,546M by 2033 · 10.1% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Radiofrequency (RF) Therapy38.4
- Laser Therapy15.6
- Acoustic Wave Therapy19.2
- Cryolipolysis18.1
- Ultrasound Therapy8.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$998.3M → $2,198M · 10.4%
Europe$695.8M → $1,419M · 9.3%
Asia Pacific$635.3M → $1,402M · 10.4%
Latin America$393.3M → $914.6M · 11.1%
Middle East and Africa$302.5M → $612.2M · 9.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.092026
10.102027
10.102028
10.112029
10.132030
10.152031
10.162032
10.162033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Cynosure Inc.13.3
- Cutera Inc.15.9
- Syneron Medical Ltd.14.9
- BTL Industries Inc.5.9
- Venus Concept Inc.9.8
- Alma Lasers Ltd.12.2
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Treatment Technology21.8%
End-User24.1%
Application Area27.0%
Treatment Modality10.4%
Patient Demographics16.8%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.6
- Europe21.7
- Asia Pacific21.4
- Latin America14.0
- Middle East and Africa9.4
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Cynosure Inc. | 74 | 78 | 91 | 78 | 92 | 91 | 84 |
| Cutera Inc. | 89 | 79 | 70 | 92 | 74 | 81 | 81 |
| Syneron Medical Ltd. | 81 | 84 | 87 | 77 | 74 | 69 | 79 |
| BTL Industries Inc. | 66 | 66 | 67 | 57 | 61 | 57 | 62 |
| Venus Concept Inc. | 57 | 75 | 71 | 56 | 73 | 56 | 65 |
| Alma Lasers Ltd. | 62 | 65 | 65 | 53 | 53 | 56 | 59 |
| Lumenis Ltd. | 62 | 57 | 49 | 48 | 61 | 60 | 56 |
| Solta Medical | 53 | 35 | 39 | 38 | 47 | 48 | 43 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Cynosure Inc.
- Cutera Inc.
- Syneron Medical Ltd.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Cynosure Inc. | − | ◐ | ◐ | ✓ | ◐ | ✓ |
| Cutera Inc. | ✓ | ◐ | ◐ | ✓ | ✓ | ✓ |
| Syneron Medical Ltd. | ✓ | ◐ | ✓ | ◐ | ◐ | ◐ |
| BTL Industries Inc. | ◐ | ◐ | ◐ | ◐ | ◐ | − |
| Venus Concept Inc. | ◐ | ◐ | ◐ | − | ◐ | ◐ |
| Alma Lasers Ltd. | ◐ | ✓ | ◐ | − | − | − |
| Lumenis Ltd. | − | ◐ | − | − | − | ◐ |
| Solta Medical | ◐ | − | ◐ | ◐ | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Cynosure Inc.84
2Cutera Inc.81
3Syneron Medical Ltd.79
4Venus Concept Inc.65
5BTL Industries Inc.62
6Alma Lasers Ltd.59
7Lumenis Ltd.56
8Solta Medical43
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Cynosure Inc.Cutera Inc.Syneron Medical Ltd.
Contender3
Focused players with pockets of strength.
BTL Industries Inc.Venus Concept Inc.Alma Lasers Ltd.
Niche2
Specialists in a single segment or region.
Lumenis Ltd.Solta Medical
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Treatment Technology in North America, then scale across Non-surgical Cellulite Reduction Treatment Market — a $293M beachhead inside a $4.30B market.
Beachhead (SOM)$293Mobtainable near-term
Serviceable (SAM)$1.64Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Radiofrequency (RF) Therapy
Best fit — highest urgency & budget in Treatment Technology.
Economic buyer81 fit
Laser Therapy
Strong fit — clear ROI and a fast path to value.
End user65 fit
Acoustic Wave Therapy
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Treatment Technology in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End-User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application Area
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales41%
Partner / channel29%
Digital / self-serve22%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Treatment Technology leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Non-surgical Cellulite Reduction Treatment Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified46%
Sales qualified20%
Evaluation13%
Closed-won6%
$18.7KCAC
$96KLTV
5.1:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Non-surgical Cellulite Reduction Treatment Market is a resilient opportunity — $5.13B by 2033, compounding at 6.0%.
TAM · 2025$3.22Btoday
TAM · 2033$5.13Bforecast
CAGR6.0%2027–2033
Cumulative$37.0Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.13BTotal addressable market
SAM$1.75BServiceable available market
SOM$304MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.0% CAGR
Demand compounds through 2033, outpacing GDP across Treatment Technology.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Treatment Technology moving from early to mainstream — durable secular demand.
Consolidation upside
17+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.13BLarge & growingTAM by 2033 at 6.0% CAGR
$1.75BServiceable nowreachable with today’s model
$304MBeachhead winobtainable near-term share
17+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.00BBear3.9% CAGR
$5.13BBase6.0% CAGR
$6.57BBull7.9% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End-User optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Non-surgical Cellulite Reduction Treatment Market — a $8.54B market by 2033. Plan: grow share from 10.2% to 18.9%.
Market size · 2033$8.54Btotal addressable
Market CAGR6.4%2027–2033
Target share18.9%from 10.2% today
Revenue ambition$1.61Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.2% | 18.9% | Ahead |
| Revenue | $880M | $1.61B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 33.1% | 41.4% | At risk |
| Customer retention | 84.1% | 92.6% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Treatment Technology
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End-User capability
A defensible second engine — invest in End-User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Treatment Technology share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End-User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $238M capacity & capability investment
- Greenlight bolt-on M&A in End-User
- Authorise North America expansion plan
- Fund R&D program for Treatment Technology leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossBehind
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Non-surgical Cellulite Reduction Treatment Market conversation — a $2.51B market you can size, segment and defend in minutes.
Market size · 2033$2.51Btotal opportunity
Growth4.1%CAGR to 2033
Addressable buyers1,445+accounts in scope
Typical ROI6.2×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Treatment Technology
Goal Grow share in Treatment Technology
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.2×return on cost, year one
< 2 mopayback period
$80K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
17+players profiled in this market
Coverage includes
Cynosure Inc.Cutera Inc.Syneron Medical Ltd.BTL Industries Inc.Venus Concept Inc.Alma Lasers Ltd.Lumenis Ltd.Solta Medical+9 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Non-surgical Cellulite Reduction Treatment Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Non-surgical Cellulite Reduction Treatment Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Anhydrous DMF Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportAminomercuric Chloride Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportBismuth Subnitrate Market
Market size, share, segmentation and regional forecast.
$489M market · 2025 base year
View reportOrthopedic Bone Graft Substitutes Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportPharma Blisters Packaging Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportEnvelope Tracking Chips for Medical Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportENT Workstations and Chairs Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportENT Video Otoscope Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportENT Treatment Units Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportENT Treatment Chair Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportENT Tables Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportENT Suture Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.